Incontinentia pigmenti case series: Clinical spectrum of incontinentia pigmenti in 53 female patients and their relatives

Clinical and Experimental Dermatology

Volumn 30, Issue 5, 2005, Pages 474-480

  Phan, T A ^a   Wargon, Orli ^b   Turnert, A M ^b,c  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HYPOPIGMENTATION; INCONTINENTIA PIGMENTI; NEUROLOGICAL COMPLICATION; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; BRAIN DISEASES; CHILD; EYE ABNORMALITIES; FEMALE; HUMANS; INCONTINENTIA PIGMENTI; PHENOTYPE; RETROSPECTIVE STUDIES;

EID: 23044439779     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01848.x     Document Type: Article

References (31)

1. Berlin AL, Paller AS, Chan LS. Incontinentia pigmenti. a review and update on the molecular basis of pathophysiology. J Am Acad Dermatol 2002; 47: 169-87.
2. Smahi A, Courtois G, Vabres P et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 2000; 405: 466-72.
3. Moss C. Cytogenetic and molecular evidence for cutaneous mosaicism: the ectodermal origin of Blaschko lines. Am J Med Genet 1999; 85: 330-3.
4. Hamm H. Cutaneous mosaicism of lethal mutations. Am J Med Genet 1999; 85: 342-5.
5. Lamartine J. Towards a new classification of ectodermal dysplasias. Clin Exp Dermatol 2003; 28: 351-5.
6. Aradhya S, Courtois G, Rajkovic A et al. Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma). Am J Hum Genet 2001; 68: 765-71.
7. Happle R. A fresh look at incontinentia pigmenti. Arch Dermatol 2003; 139: 1206.
8. Kunze J, Frenzel UH, Huttig E et al. Klinefelter's syndrome and incontinentia pigmenti Bloch-Sulzberger. Hum Genet 1977; 35: 237-40.
9. Garcia-Dorado J, de Unamuno P, Fernandez-Lopez E et al. Incontinentia pigmenti: XXY male with a family history. Clin Genet 1990; 38: 128-38.
10. Ormerod AD, White MI, McKay E, Johnston AW. Incontinentia pigmenti in a boy with Klinefelter's syndrome. J Med Genet 1987; 24: 439-41.
11. Carney RG. Incontinentia pigmenti. A world statistical analysis. Arch Dermatol 1976; 112: 535-42.
12. van Leeuwen RL, Wintzen M, van Praag MC. Incontinentia pigmenti. an extensive second episode of a 'first-stage' vesicobullous eruption. Pediatr Dermatol 2000; 17: 70.
13. Bodak N, Hadj-Rabia S, Hamel-Teillac D et al. Late recurrence of inflammatory first-stage lesions in incontinentia pigmenti: an unusual phenomenon and a fascinating pathologic mechanism. Arch Dermatol 2003; 139: 201-4.
14. Moss C, Ince P. Anhidrotic and achromians lesions in incontinentia pigmenti. Br J Dermatol 1987; 116: 839-49.
15. Nazzaro V, Brusasco A, Gelmetti C et al. Hypochromic reticulated streaks in incontinentia pigmenti: an immunohistochemical and ultrastructural study. Pediatr Dermatol 1990; 7: 174-8.
16. Landy SJ, Donnai D. Incontinentia pigmenti (Bloch-Sulzberger syndrome). J Med Genet 1993; 30: 53-9.
17. Hadj-Rabia S, Froidevaux D, Bodak N et al. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol 2003; 139: 1163.
18. Spallone A. Incontinentia pigmenti (Bloch-Sulzberger syndrome): seven case reports from one family. Br J Ophthalmol 1987; 71: 629-34.
19. O'Brien JE, Feingold M. Incontinentia pigmenti. A longitudinal study. Am J Dis Child 1985; 139: 711-2.
20. Wiklund DA, Weston WL. Incontinentia pigmenti. A four-generation study. Arch Dermatol 1980; 116: 701-3.
21. Reed WB, Carter C, Cohen TM. Incontinentia pigmenti. Dermatologica 1967; 134: 243-50.
22. Iancu T, Komlos L, Shabtay F et al. Incontinentia pigmenti. Clin Genet 1975; 7: 103-10.
23. Chan YC, Giam YC. A retrospective study of incontinentia pigmenti seen at the National Skin Centre, Singapore over a 10-year period. Ann Acad Med Singapore 2001; 30: 409-13.
24. Basarab T, Dunnill MG, Munn SE, Russell-Jones R. Incontinentia pigmenti: variable disease expression within an affected family. J Eur Acad Dermatol Venereol 1998; 11: 173-6.
25. Dutheil P, Vabres P, Cayla MC, Enjolras O. Incontinentia pigmenti: late sequelae and genotypic diagnosis: a three-generation study of four patients. Pediatr Dermatol 1995; 12: 107-11.
26. Hennel SJ, Ekert PG, Volpe JJ, Inder TE. Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti. Pediatr Neurol 2003; 29: 148-50.
27. Heathcote JG, Schoales BA, Willis NR. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a case report and review of the ocular pathological features. Can J Ophthalmol 1991; 26: 229-37.
28. Francis JS, Sybert VP. Incontinentia pigmenti. Semin Cutan Med Surg 1997; 16: 54-60.
29. Lee AG, Goldberg MF, Gillard JH et al. Intracranial assessment of incontinentia pigmenti using magnetic resonance imaging, angiography, and spectroscopic imaging. Arch Pediatr Adolesc Med 1995; 149: 573-80.
30. Cates CA, Dandekar SS, Flanagan DW, Moore AT. Retinopathy of incontinentia pigmenti: a case report with thirteen years follow-up. Ophthalmic Genet 2003; 24: 247-52.
31. Aradhya S, Woffendin H, Jakins T et al. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet 2001; 10: 2171-9.